[HTML][HTML] αβ T cell receptors as predictors of health and disease

M Attaf, E Huseby, AK Sewell - Cellular & molecular immunology, 2015 - nature.com
Cellular & molecular immunology, 2015nature.com
The diversity of antigen receptors and the specificity it underlies are the hallmarks of the
cellular arm of the adaptive immune system. T and B lymphocytes are indeed truly unique in
their ability to generate receptors capable of recognizing virtually any pathogen. It has been
known for several decades that T lymphocytes recognize short peptides derived from
degraded proteins presented by major histocompatibility complex (MHC) molecules at the
cell surface. Interaction between peptide-MHC (pMHC) and the T cell receptor (TCR) is …
Abstract
The diversity of antigen receptors and the specificity it underlies are the hallmarks of the cellular arm of the adaptive immune system. T and B lymphocytes are indeed truly unique in their ability to generate receptors capable of recognizing virtually any pathogen. It has been known for several decades that T lymphocytes recognize short peptides derived from degraded proteins presented by major histocompatibility complex (MHC) molecules at the cell surface. Interaction between peptide-MHC (pMHC) and the T cell receptor (TCR) is central to both thymic selection and peripheral antigen recognition. It is widely assumed that TCR diversity is required, or at least highly desirable, to provide sufficient immune coverage. However, a number of immune responses are associated with the selection of predictable, narrow, or skewed repertoires and public TCR chains. Here, we summarize the current knowledge on the formation of the TCR repertoire and its maintenance in health and disease. We also outline the various molecular mechanisms that govern the composition of the pre-selection, naive and antigen-specific TCR repertoires. Finally, we suggest that with the development of high-throughput sequencing, common TCR ‘signatures’ raised against specific antigens could provide important diagnostic biomarkers and surrogate predictors of disease onset, progression and outcome.
nature.com